Fact CheckerSign in

NCT06199570Recruiting

Support for Cancer Patients Awaiting News

Support for Cancer Patients Awaiting News (SCAN Study): Pilot Testing a Stress Management Program

Source: ClinicalTrials.gov · Last updated 4 Aug 2026

Brief summary (registry, in English)

This is a behavioral trial study to pilot test a stress management intervention for people with cancer who are undergoing routine cancer scans. The study will involve two pilot testing phases. Initial feasibility will be determined in an Open Trial phase, to inform any needed revisions to the intervention and/or protocol prior to a Pilot Randomized Controlled Trial phase. The Open Trial phase is an unblinded, single-site, single-arm open trial (n=10). The Pilot randomized clinical trial (RCT) phase is an unblinded, single-site, feasibility pilot randomized controlled trial (n=50).

Status (registry)
Recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
8 Dec 2023
Start date
1 May 2024
Primary completion date
1 Jul 2027
Lead sponsor
Hackensack Meridian Health
Diseases
Lung cancer
NCT number
NCT06199570

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 1 May 2024 to the primary completion date, 1 Jul 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Moderate-to-severe cognitive impairment (per dementia diagnosis or cognitive screen)
  • Severe psychiatric illness (psychiatric hospitalization in the past year, or substance use disorder, bipolar disorder, or psychosis diagnosis)

Other

  • Requires an interpreter for medical visits
  • Currently enrolled in hospice
  • Unable to complete study activities per oncology provider's judgment (e.g., due to fatigue)

Who the study is looking for

  • Adult (ages 18 and older)
  • Comfortable speaking, reading, and writing English without an interpreter
  • Established diagnosis of lung cancer (3a. Open Trial phase only: Stage III-IV lung cancer or extensive stage small cell lung cancer)
  • ECOG (Eastern Cooperative Oncology Group) performance status of 0 to 2
  • Receiving ongoing care from collaborating clinics with regular scans
  • Receiving systemic treatment for lung cancer
  • Endorse at least mild anxiety (using the PROMIS Anxiety 4a) or appointment- or scan-related stress on 4-item screen (using a modified Distress Thermometer item, a Fear of Progression scale item, an Impact of Events scale item, and an item from our prior study)
  • Willingness to use the study website

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Amanda Khoudary
Coordinator of this site? Confirm its status
HackensackUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.